{"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"3"},{"groupId":"OG001","value":"3"}]}],"title":"Fever"},{"categories":[{"measurements":[{"groupId":"OG000","value":"28"},{"groupId":"OG001","value":"30"}]}],"title":"Neutrophil count decreased"}],"denoms":[{"counts":[{"groupId":"OG000","value":"49"},{"groupId":"OG001","value":"50"}],"units":"Participants"}],"groups":[{"description":"* Two 8 oz. bottles of Enterade will be administered daily\n* Enterade will be given orally from admission until day +14 or until discharge\n* Standard Supportive Care will be administered according to institution's practice\n\nEnterade\n\nStandard Supportive Care","id":"OG000","title":"Enterade and Standard Supportive Care"},{"description":"* Two 8 oz. bottles of Placebo will be administered daily\n* Placebo will be given orally from admission until day +14 or until discharge\n* Standard Supportive Care will be administered according to institution's practice\n\nPlacebo\n\nStandard Supportive Care","id":"OG001","title":"Placebo and Standard Supportive Care"}],"paramType":"COUNT_OF_PARTICIPANTS","populationDescription":"Only 17 participants met the protocol definition of compliance","reportingStatus":"POSTED","timeFrame":"14 days","title":"Number of Participants With Fever or Neutropenia","type":"SECONDARY","unitOfMeasure":"Participants"}